Comparing stroke and bleeding with rivaroxaban and dabigatran in atrial fibrillation: analysis of the US Medicare Part D data

I Hernandez, Y Zhang - American Journal of Cardiovascular Drugs, 2017 - Springer
Background No studies have directly compared the effectiveness and safety of dabigatran
and rivaroxaban using US Medicare data. Objective Our objective was to compare …
被引用次数：81 相关文章

Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data

I Hernandez, Y Zhang - American Journal of Cardiovascular Drugs, 2016 - infona.pl
Background No studies have directly compared the effectiveness and safety of dabigatran
and rivaroxaban using US Medicare data. Objective Our objective was to compare …
[HTML] nih.gov

[HTML][HTML] Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data

I Hernandez, Y Zhang - American journal of cardiovascular drugs …, 2017 - ncbi.nlm.nih.gov
Background No studies have directly compared the effectiveness and safety of dabigatran
and rivaroxaban using US Medicare data. The objective of the study was to compare the …

Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data

I Hernandez, Y Zhang - American journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background No studies have directly compared the effectiveness and safety of dabigatran
and rivaroxaban using US Medicare data. Objective Our objective was to compare …

Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data.

I Hernandez, Y Zhang - American Journal of Cardiovascular Drugs …, 2017 - europepmc.org
Background No studies have directly compared the effectiveness and safety of dabigatran
and rivaroxaban using US Medicare data. Objective Our objective was to compare …

Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data.

I Hernandez, Y Zhang - American Journal of Cardiovascular Drugs …, 2017 - europepmc.org
Background No studies have directly compared the effectiveness and safety of dabigatran
and rivaroxaban using US Medicare data. Objective Our objective was to compare …